Omegaven
Drug Parental Nutrition
NDC 63323-205-50
General payments
$2,681,070
Research payments
$977,939
Through program year 2025, $2,681,070 in general payments and $977,939 in research payments were reported against Omegaven (Parental Nutrition).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,116,119 | 15 |
| 2025 | Research | $287,482 | 323 |
| 2024 | General | $775,982 | 5 |
| 2024 | Research | $20,219 | 4 |
| 2023 | General | $786,904 | 13 |
| 2023 | Research | $86,223 | 23 |
| 2022 | General | $291 | 5 |
| 2022 | Research | $584,014 | 8 |
| 2019 | General | $1,774 | 18 |
Breakdown
The top 5 of 11 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
56 general · 358 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.